South Korea In-Vitro Diagnostics Market is predicted to reach USD 3.34 Billion by 2030

According to the study by Next Move Strategy Consulting, the South Korea In-Vitro Diagnostics Market size is predicted to reach USD 3.34 billion, at a CAGR of 5.2% by 2030.

Request a FREE Sample: https://www.nextmsc.com/south-korea-in-vitro-diagnostic-market/request-sample

The increase in aging population drives the growth of the in-vitro diagnostics market in South Korea.

The rising healthcare expenditure further drives the demand for the in-vitro diagnostics. South Korea spends USD 4,570 per capita on health which accounts for 9.7% of the country’s GDP.

The promising players operating in the South Korea in-vitro diagnostics industry include Roche Holding AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Danaher Corporation, Becton, Dickinson and Company, Siemens Healthineers AG, bioMérieux SA, Sysmex Corporation, QIAGEN N.V., and Bio-Rad Laboratories, Inc., and others.